ZEISS VisioGen — 90-Day Marketing Campaign

Step 1 of 9The bet

The first 90 days buy understanding, not scale.

This tab

The objective, target and budget, and the four parts the rest of the deck covers.

Key terms

Read these first

used throughout

ICPIdeal Customer Profile — the type of practice worth targeting. We map three buyer tiers (T1/T2/T3) plus a non-buyer influence layer.

TOFU / MOFU / BOFUTop / Middle / Bottom of funnel — how far along a buyer is, from "just curious" to "ready to buy".

A vs CAssume vs Confirm. (A) pain we infer before contact; (C) pain only the prospect can confirm in a conversation.

Fit → Intent → QualificationThe three scores: does it look right, are they interested, is there a real deal.

Campaign objective

Area	Strategy
Primary objective	Understand practices' patient-inquiry challenges, create qualified engagement, and convert the strongest accounts into Sales opportunities — then build a repeatable demand-generation engine.
Commercial target	100 qualified leads.
90-day priority	Determine which ICP, buyer, problem, message and channel combination generates the strongest qualified demand.
Budget	₹10 lakh across 3 months.
Marketing focus	Positioning, messaging, ICP learning and demand strategy (60%); channels and execution (40%).
Core principle	Do not assume the customer's problem. Use the funnel to progressively discover, validate and qualify it.

The four moving parts

what the tabs unpack

1 · Foundation — who & why (Tabs 2–3)

Three ICP tiers, and a clear line between what we can observe before contact and what we can only confirm in a conversation. That line drives the scoring: Fit → Intent → Qualification.

2 · Message & creative (Tab 4)

One positioning, three tier expressions, message territories to test, two copy angles per segment — plus a "do not say" list that keeps assumed pain a question, not a claim.

3 · Execution engine (Tabs 5–6)

The journey, channels and buyer routing, email arcs and Sales Navigator triggers — built around a 60-second benchmark that makes pain surface instead of being asserted.

4 · Plan & proof (Tabs 7–9)

A 90-day Discover → Validate → Scale plan, lead scoring, a ₹10L budget with a Day-60 reallocation reserve, learning-first KPIs, and the team that runs it.

The idea underneath everything

Each funnel stage answers a different question:

ICP

Where to look

Fit signals indicate where to spend attention.

TOFU

What gets attention

The segment's recognizable moment.

MOFU

What actually matters

Benchmark + snapshot make pain surface.

BOFU

Is VisioGen relevant

Resolves the segment's specific fear.

Sales

Real opportunity?

Discovery confirms the pain.

Loop

Back to marketing

Feedback rewrites ICP + messaging.

Step 2 of 9Who

Market segmentation & pain mapping.

This tab

Who we target (three buyer tiers + a referral partner), how we source them, and how we score an account before we know its pain.

2.1

Market context

~18,500

practicing ophthalmologists in the U.S.

~4,000

private ophthalmic practices — the buyer unit (not individual MDs).

~70%

remain independent → fast owner-operator decisions.

Two engines

Refractive (~800K LASIK/yr, cash-pay) & Cataract (~4M/yr; only ~15–18% choose premium IOLs vs ~20–25% interest — the attach-rate gap is the wedge).

2.2

The three ICPs

Primary · Secondary · Tertiary

✅ = we can see this before contact · ❓ = only a conversation confirms it

Tier 1 · Primary

Refractive / Lifestyle Hubs

Decision-maker: Managing MD-partner or Marketing / Growth Director

Profile: Multi-surgeon LASIK/SMILE/ICL/RLE practices, 3–15 surgeons, 1–10 locations, marketing-driven, cash-pay revenue.

✅ Observable fit signals: refractive marketing, paid acquisition (Google/Meta), refractive SEO spend, "Am I a candidate?" quiz, live chat, ZEISS equipment (VisuMax, MEL), CareCredit financing, dedicated refractive brand, high review velocity, owner-operated.

❓ Confirm-only: inquiry volume, after-hours %, consult-to-procedure conversion, current tools, dissatisfaction, budget/timing.

Tier 2 · Secondary

Premium-Cataract Groups

Decision-maker: Practice Administrator or lead cataract surgeon

Profile: Comprehensive groups, 3–15 surgeons, often ASC-anchored, thousands of Medicare cataracts, seeking to help patients understand premium-IOL options.

✅ Observable fit signals: premium lens marketing (PanOptix, Vivity, LAL, toric), ASC ownership, comprehensive branding, ZEISS diagnostics (IOLMaster), admin/marketing role, patient-education / lens-comparison pages.

❓ Confirm-only: actual attach rate, call volume, education delivery, leadership priority, staffing bandwidth.

Tier 3 · Tertiary

PE-Backed Platforms

Decision-maker: COO / VP Operations / VP Marketing at parent

Profile: MSO roll-ups, 15–700+ locations, multiple regional brands, hub-and-spoke call centers.

✅ Observable fit signals: named PE/MSO ownership, location count / multi-brand structure, centralized call-center hiring, refractive/premium arms, EHR platform (integration signal), COO / VP roles visible.

❓ Confirm-only: call-center turnover, overload, comms inconsistency, procurement timeline, vendor stack, champion, budget cycle.

Plus — the influence layer (not a buyer)

Segment 4 · Influence · not a buyer

Ophthalmic Practice-Management Consultancies

Advisors, fractional COOs & practice-management firms serving many ophthalmology practices

Profile: Independent consultants and advisory firms working on growth, operations, staffing, patient conversion and training across multiple practices.

Why they matter: not the primary user or buyer — but one consultant influences dozens of practices. Best worked as a referral, channel or advisory partner, not a sales target.

Play: co-marketing + a referral relationship (executed in Channels, Tab 6) so a trusted advisor recommends VisioGen into their book of practices.

2.3

How we find them (sourcing)

build the 500–1,000 account universe

Segment	Where we source them	Enrich with
T1 Refractive / premium	Google Maps & Search ("LASIK center", "refractive surgery", "premium cataract"); ophthalmology directories & associations; LinkedIn (owners, managing partners, administrators)	Locations, services, digital presence, growth signals, decision-makers
T2 Multi-location groups	LinkedIn Sales Navigator (ophthalmology + multiple locations); Google/Maps location networks; practice-site location & provider pages	Location count, centralization, service lines, access model
T3 PE / MSO platforms	PE portfolio pages; healthcare M&A news; company sites; LinkedIn / Sales Navigator	Acquisition & expansion triggers, shared-services structure
Inf Consultancies	LinkedIn ("ophthalmology consultant", "ophthalmic practice management", "practice administrator consultant"); Google; ASOA / events & communities	Firms with multiple ophthalmology clients

2.4

Consolidated pain map

A = assume · C = confirm

Problem	Type	Segment hit hardest
Lead leakage / slow speed-to-lead	A	Tier 1
After-hours coverage gap	A	All
Front-desk overload	A	Tier 2, All
Premium-IOL education gap	A	Tier 2
Brand & compliance risk	A	Tier 1, Tier 3
Inconsistency / no visibility	A	Tier 3
Rising CAC / conversion pressure	A	Tier 1
Workforce strain (aging demand, shortage)	A	All (macro)
Actual inquiry volume, response time, attach rate, staffing pain, willingness to change	C	Per account

2.5

How do we score an ICP if we don't know their pain?

We don't score an account high just for looking like a fit. Three layers instead:

Score	Question it answers	When
Account Fit Score	Does this account look like the type of practice VisioGen is built for?	Before engagement
Engagement / Intent Score	Are they showing meaningful interest in the problem or solution?	During marketing engagement
Qualification Score	Is there an actual business problem, relevant buyer and buying intent?	After human interaction

Can observe (pre-engagement)

Ophthalmology practice · number of locations
Premium/refractive services
Digital presence · inquiry/contact mechanisms
Marketing activity · growth triggers
Ownership/group structure · relevant buyer

Cannot yet know

Actual inquiry volume · after-hours volume
Response times · front-desk workload
Current conversion rate · internal workflow
Whether they actually want to change

Step 3 of 9Who · why they hurt

Split by revenue engine.

This tab

The root problem behind each tier, and where VisioGen fits. Each table: problem → what it costs → VisioGen's role.

Refractive Hubs — "they buy their patients"

Customer problem	What's happening	Business impact	What they need	VisioGen's role
Paid-demand leakage (speed)	A lead they paid for cools before anyone replies (nights/weekends is one slice)	CAC spent, no consult booked	Instant capture of every paid inquiry	Always-on, verified first response
Wasted consult capacity	Coordinators & consult slots burned on non-candidates	Rising cost-per-booked-consult	Front-end candidacy qualification	AI pre-qualifies, OD-verified
Nurture drop-off	"Researching, not ready" prospects drift with no follow-up	Pipeline decays silently	Structured follow-up	Ongoing verified engagement
Single-channel dependency	Growth rides one ad account / algorithm	Fragile, pay-for-every-lead economics	More yield from spend already committed	Conversion multiplier on existing funnel
Chatbot brand-risk	Won't put unmoderated AI on a reputation-critical site	Can't adopt the speed tools they need	Speed without the gamble	Licensed OD signs every answer

Premium-Cataract Groups — "patients arrive; a decision must be won"

Customer problem	What's happening	Business impact	What they need	VisioGen's role
Off-site decision window	Lens choice made alone, over weeks, between two short visits	Attach rate below real potential	Presence in the decision, not just the exam	Verified education across the journey
Education bottleneck	No time for 20-minute lens conversations at scale	Premium conversion stalls; desk strain	First-line education without added staff	AI handles repeatable lens education
Patient anxiety / misinformation	Patient Googles at 11pm, gets confused or scared	Defaults to standard, or delays	Clear, credible info in the practice's voice	Verified, on-brand explanations
Inconsistent education	Each counselor explains lenses differently	Uneven conversion, mixed experience	Repeatable education standard	Standardized education workflow
"Feels like selling"	Fear an upsell tool erodes trust	Reluctance to automate	Education-first, not sales-first	OD-verified, informative not pushy

PE Platforms — "growth by acquisition → owns heterogeneity"

Customer problem	What's happening	Business impact	What they need	VisioGen's role
Cross-brand variance	Dozens of brands answer patients differently	Brand dilution, uneven experience	One standard everywhere	Standardized verified layer
Compliance exposure at scale	HIPAA variance across sites; AI risk × every location	Regulatory + reputational risk	Governable, auditable comms	HIPAA compliant by design, logged workflow
Call-center turnover/overload	Churn, rehiring, inconsistent scripts	Recurring cost, margin pressure	Deflect routine volume	AI first-line + consistency
No portfolio visibility	HQ can't see or oversee interactions	Uncertainty, no audit trail	Central oversight + reporting	Structured inquiry reporting
AI-risk ownership	Want AI leverage, can't own the liability	Adoption stalls	AI leverage without the exposure	Human verification = the control

Step 4 of 9What we say

One spine, three expressions.

This tab

The shared positioning, how it flexes per tier, the messages to test, and two copy angles per segment.

4.1

Shared core positioning

The spine (unchanged for all three)

Human-Verified AI patient communication for ophthalmology — every patient question deserves a verified answer.

Differentiator: AI prepares. A ZEISS-trained OD verifies. The patient receives.

Human-Verified AI HIPAA compliant Built exclusively for ophthalmology Licensed optometrist review

Claim boundary: VisioGen is not a medical device. No diagnoses, medical advice or treatment recommendations — messaging stays in communication and education support only.

4.2

What flexes per segment

Segment	Value-prop expression	Point of view (the "why care")
T1	"Respond to the demand you already paid for."	You're not losing patients to the surgeon down the road — you're losing the leads you already bought to internal friction.
T2	"Be there for the decision you're not in the room for."	The lens decision isn't made in your chair; it's made alone, at home, over weeks. Extend your clinical voice into that window.
T3	"One verified standard. Every location."	At portfolio scale, one inconsistent answer stops being a coaching issue and becomes a compliance exposure you own.

4.3

Messaging territories to test

Territory	Example	Best-fit
RETURN	"You paid for that inquiry. What happens to it?"	T1
ACCESS	"A patient reaches out after hours. What happens next?"	T1
INFLUENCE (new)	"The lens decision happens where you're not. Be there anyway."	T2
CAPACITY	"More capacity for the conversations that matter."	T2
CONSISTENCY (new)	"Should forty brands answer forty different ways?"	T3
CONTROL	"Automate the response. Keep professional oversight."	T3
TRUST	"The efficiency of AI. The confidence of verification."	All

To test per tier: T1 → RETURN + ACCESS · T2 → INFLUENCE + CAPACITY · T3 → CONTROL + CONSISTENCY. TRUST runs under all three.

4.4

Copy directions — two angles per segment

T1 · Angle A — The demand you already paid for

The click is not where the patient is won. It is where they start waiting.

Paid leads often arrive after hours, and a slow reply loses them. VisioGen answers every inquiry 24/7, verified by a ZEISS-trained optometrist.

T1 · Angle B — Systems, not heroics

Conversion should not depend on whether your coordinator had a good day.

Fast response shouldn't rely on staff memory or a next-day callback — and an unmoderated chatbot adds risk. VisioGen is 24/7, every answer approved by a licensed optometrist.

T2 · Angle A — The decision you are not in the room for

The lens decision is rarely made in your chair. It is made at home, over weeks.

Patients research alone between visits and often default to the standard lens. VisioGen carries your verified voice into that window with clear premium-lens education.

T2 · Angle B — Capacity without a sales pitch

Your best people should not spend the day answering the same lens questions.

The same 20-minute lens conversation, a hundred times, can't be staffed. VisioGen handles first-line lens education in your voice — accurate, and not an upsell.

T3 · Angle A — Scale the front door, not the liability

The question is not whether AI belongs in patient communication. It is who is accountable for it.

Everyone wants AI leverage; no one wants to own what an unmoderated bot says at 700 locations. VisioGen is the governance layer — one verified standard, HIPAA compliant, auditable.

T3 · Angle B — The variance you cannot see

You standardized billing and scheduling. Patient communication is still forty different answers.

Inconsistent first impressions dilute every brand you acquired, and HQ can't see them. VisioGen makes every inquiry consistent, verified and visible from one place.

Step 5 of 9How they move

The funnel as a research mechanism.

This tab

How a buyer moves from "is this relevant?" to a sales conversation, and what each step tells us. Journey: Target → Awareness → Engagement → Learning → Qualification → Experience → Sales.

5.1

The customer journey (shared chassis)

Stage	Mindset	What we know	Objective	CTA
TOFU	"Is this relevant?"	Account + basic engagement	Problem awareness	Learn / Watch
MOFU	"How are others handling this?"	Role + self-reported info	Explore the problem	Benchmark / Compare
MOFU→BOFU	"Could this work for us?"	Account + problem + intent	Show the operating model	See VisioGen
BOFU	"Let's evaluate."	Fit + problem + buyer + intent	Qualified sales conversation	Live walkthrough
Sales	"Worth implementing?"	Validated need + stakeholders + timing	Evaluate	Discovery

5.2

Buyer journey by ICP

T1 · Refractive

Owner / Marketing Director

TOFU: "You paid for that inquiry. What happens to it?"

MOFU: "How are refractive practices converting paid demand today?"

BOFU: "See how VisioGen converts your own after-hours and unqualified inquiries."

Qualify on: paid-acquisition dependence + response gap + buyer interest.

T2 · Premium Cataract

Administrator / Lead Surgeon

TOFU: "Where does the premium-lens decision actually happen?"

MOFU: "How practices support patients through the lens decision between visits."

BOFU: "See how VisioGen educates your patients in your voice, 24/7."

Qualify on: premium ambition + education bottleneck + buying intent.

T3 · PE Platforms

Platform COO / VP Ops · ABM

TOFU: Executive POV — "AI leverage without AI liability, at scale."

MOFU: Private benchmark + "Chairs & Cheers" roundtable on cross-brand communication (see 6.7).

BOFU: Strategic operating-model + single-brand pilot proposal.

Qualify on: strategic priority + scale + executive sponsorship. (Pilot to de-risk procurement.)

5.3

TOFU → MOFU → BOFU mechanics

TOFU — create the question

A recognizable moment, not a statistic:

T1: "A patient reaches out at 8:47 PM. What happens next?"
T2: "Your patient chooses their lens at 11 PM, alone. Where are you?"
T3: "Forty brands. Forty different answers. One name on the compliance report."

MOFU — make pain surface

Benchmark (60-sec): same instrument, segment-weighted questions — funnel economics (T1), decision journey (T2), governance (T3).

Interactive calculators (high-intent, search-promoted): e.g. a Refractive Conversion-Rate Calculator (T1), premium attach-rate / revenue-per-chair (T2), or a no-show / after-hours-loss estimator — owners run their own numbers.

Snapshot: "See your practice through a new patient's eyes" — an observational snapshot, never a fake score.

BOFU — experience VisioGen

Shared demo (AI prepares → OD verifies → patient receives → practice gets inquiry + summary). What changes is the fear it resolves:

T1: "Fast = a brand-risky bot"
T2: "This is an upsell bot"
T3: "AI at scale = risk at scale"

5.4

The full Ad → Sales journey

funnel as research

Step	Customer experience	What we learn
1	Sees the segment's TOFU moment (ad / media)	Account + initial interest
2	Engages the scenario (landing / content)	Problem interest
3	Answers segment-weighted benchmark questions	Practice type + role + process
4	Returns, views workflow (engagement scoring)	Intent
5	Sees the conversation handled (VisioGen experience)	Product interest
6	Requests live experience (walkthrough)	Strong buying signal
7	Discusses current process (sales discovery)	Confirmed pain
8	Fit + problem + buyer + intent (qualification)	Sales-ready opportunity
9	Reports objections / outcomes (sales feedback)	Improves ICP + messaging

Step 6 of 9Where

Channels route by buyer — because the buyer rotates.

This tab

Where we reach each buyer, what each channel is for, and how we activate consultancy referral partners. The buyer rotates: owner → administrator → COO.

6.1

Channel strategy

Channel	Funnel role	Primary job
LinkedIn	TOFU/MOFU	Reach buyers + POV
Sales Navigator	TOFU→BOFU	Account-based engagement
Google Search	MOFU/BOFU	Capture active intent
Ophthalmology media	TOFU/MOFU	Credibility + targeted reach
Email	MOFU/BOFU	Nurture identified accounts
Executive roundtables	MOFU/BOFU	Learn + high-quality conversations
SEO (off-page)	TOFU/MOFU	Own problem-led searches
Retargeting	MOFU/BOFU	Bring engaged prospects back
Meta	TOFU test	Test problem resonance (community-targeted)
PR / thought leadership	TOFU	Category credibility
Physician networks Sermo · Doximity	TOFU/MOFU	NPI / license-verified reach — zero wasted impressions on non-decision-makers
Programmatic (NPI-matched) DeepIntent · PulsePoint · DSPs	MOFU/BOFU	Serve display/video to verified ophthalmology owners across the open web
Association communities ASCRS · ASOA	TOFU/MOFU	Member forums & lists — ASOA reaches administrators & managing partners directly
Podcasts sponsor + SME guest	TOFU	Trusted audio; owners consume on the commute (see 6.2)
Reddit r/Ophthalmology — listening only	Listening	Unfiltered pain research, not promotion (feeds discovery, Tab 7)

Precision plays: NPI-verified networks (Sermo, Doximity) and NPI-matched programmatic (DeepIntent, PulsePoint) reach license-verified owners with near-zero waste. Both paid — funded from the media / test budget (Tab 8).

6.2

Media placements by segment

reach the decision-makers who control access & budget

Placement	Reaches	Segment	Asset
EyeWorld / ASCRS · Eyetube / CRST	Refractive surgeons	T1	E-blast → demo; 5-min surgeon video (intake→consult)
Ophthalmology Management	Owners / administrators (budget)	T1 T2	Co-authored case study: practice economics + liability protection
EyeNet / AAO	Broad practicing members	T2	Sponsored feature: education, HIPAA, no hallucination
Ophthalmology 360	Busy surgeons	T1 T2	Newsletter native + ROI / attach-rate calculator
Ocular Surgery News · Healio	Practice heads (business + clinical)	T1 T2	Native white paper + co-branded editorial webinar
Review of Ophthalmology	Practicing ophthalmologists	T1 T2	Sponsored feature + dedicated e-blast to subscriber list
Podcasts · Cutter's Mouth · Eyes On Eyecare · AAO Experts InSight	Owners on the commute	T1 T2	Mid-roll sponsorship + founder / SME guest on operational efficiency
Executive roundtable	COOs / ops	T3	See roundtable (6.7)

Fast-pipeline plays: (1) sponsored e-blast — offer = "audit: how many refractive inquiries is your site losing after 5 PM?" (T1); (2) co-authored practice-economics case study (T1+T2); (3) retargeting / newsletter native snippet.

6.3

Content architecture — one idea per segment

"Respond to the demand you already paid for."

LinkedIn: "You paid for that inquiry. What happens to it?"

Blog: The Hidden Leak in Your Refractive Funnel

Video: The Lead You Already Bought

Benchmark: How Refractive Practices Convert Paid Demand

Email: What happens to your leads after you close?

Sales: How does your practice handle inquiries outside office hours?

"Be there for the decision you're not in the room for."

LinkedIn: "Where does the lens decision actually happen?"

Blog: What Your Cataract Patients Do Between Visits

Video: The 11 PM Lens Search

Benchmark: How Practices Support the Premium-Lens Decision

Email: The decision happens where you're not

Sales: How do your patients research lens options today?

"One verified standard. Every location."

Executive POV: Scaling AI Without Scaling Risk

Blog: Why Consolidation Creates a Communication Blind Spot

Roundtable: Governing Patient Communication Across a Portfolio

Private benchmark: Cross-Brand Inquiry Consistency

Email: Forty brands, one first impression

Sales: How consistent is the patient experience across your locations?

6.4

Email journey — the 5-beat arc

curiosity → benchmark → scenario → differentiation → walkthrough

Beat	T1 Refractive	T2 Premium Cataract	T3 PE Platforms
1 · Curiosity	What happens to the inquiry you paid for after 5 PM?	Where does the premium-lens decision actually happen?	What does patient communication look like across your portfolio?
2 · Benchmark	How refractive practices are converting paid demand today	How practices support the lens decision between visits	Cross-brand inquiry consistency: an operator's view
3 · Scenario	A patient reaches out at 8:47 PM.	The 11 PM lens search — your patient, deciding alone.	Forty brands. Forty different answers.
4 · Differentiation	AI prepares. A ZEISS-trained OD verifies.	Verified education, in your voice, when you're not in the room.	AI leverage with a human signature on every word.
5 · Walkthrough	See how an inquiry becomes a qualified consult.	See how VisioGen answers lens questions like your best counselor.	One verified, auditable standard for every location.

6.5

Sales Navigator strategy — trigger-led

Trigger	Why it matters	T1	T2	T3
New premium/refractive service	Inquiry growth	★★★	★★	★
New marketing activity / ad spend	Paid-acquisition signal	★★★	★	—
New website / digital consultation	Digital maturity	★★★	★★	★
Patient-coordinator hiring	Inquiry-load signal	★★	★★★	★★
New location / physician	Growth / complexity	★★	★★	★★
Acquisition	Standardization need	—	—	★★★

T1 opener

"Curious how you're handling new-patient inquiries as your ad presence grows — we're learning how refractive practices convert after-hours demand."

T2 opener

"Curious how your patients get their lens questions answered between diagnosis and surgery — happy to share what we're seeing across practices."

T3 opener

"As you integrate [acquired brand], curious how you're standardizing patient communication across locations — we're running an operator benchmark on exactly this."

Target the administrator, not just the surgeon. Run ABM against titles: "Ophthalmic Practice Administrator", "Practice Manager", "Executive Director", "COO / VP Operations". The surgeon is the user; the administrator is often the buyer.

6.6

Channel depth & off-page SEO

Depth is deliberate

Lead channel: LinkedIn Sales Navigator (trigger-led, account-based)
Scaled: Google Ads, ophthalmology media / PR, email, retargeting / roundtables
Test-only: Meta (community-targeted, folds into Google if signal isn't readable)
Lean, focused: organic social — one intentional post per week
Off-page-led: external SEO runs off-site (site isn't controlled)

Off-page SEO + AEO (off-budget)

Listings: Google Business Profile + healthcare directories (Healthgrades, Vitals, WebMD, Zocdoc)
Review platforms: G2, Capterra, GetApp, TrustRadius — where AI answer engines source vendor comparisons
Authority: AAO, ASCRS, ASOA directories; earned bylines + backlinks from media/PR/podcasts
Reputation: review volume & velocity — both an SEO and a fit signal

Off-page SEO and organic social piggyback on media/PR spend already allocated and in-house labour — neither adds to the ₹10L budget.

6.7

Executive roundtable (primarily Tier-3 ABM)

Topic: "What happens between a patient inquiry and a patient conversation?" Invite administrators, physician owners, COOs and patient-acquisition leaders.

First 30 min

No pitch

—

Discussion

How inquiries arrive

Ownership, coverage, after-hours, automation

Research

Real operating models

Understand how they actually run

VisioGen as one model

One possible approach

Follow-up

Individual conversations

First-party intelligence, not just leads

Format — "Chairs & Cheers" closed-door roundtable

6–8 practice heads, 45 minutes, invited by personal LinkedIn message. Topic: private-equity consolidation or staffing pressure — not a demo. Pair attendance with a dinner or wine delivery.

6.8

Referral & channel partners — consultancies

the influence layer, activated

Who

Independent ophthalmology consultants, fractional COOs and practice-management / patient-conversion advisory firms — sourced on LinkedIn and via ASOA communities (see 2.3).

The offer

Co-marketing (co-branded webinars, shared benchmarks, guest content) plus a referral arrangement, so recommending VisioGen makes their advice look good — a better-run front desk for their client.

Why it compounds

A trusted advisor's recommendation clears the trust and access hurdle that cold outreach can't. One partner can open a book of qualified T1/T2 practices.

Step 7 of 9When

Discover → Validate → Scale.

This tab

The 90 days in three phases, how we score leads, and how we equip Sales.

7.1

The three phases

Days 1–30 · 31–60 · 61–90

Days 1–30

DISCOVER

ICPBuild 500–1,000 account universe

ResearchEnrich signals · 10–15 practice interviews

BuyersIdentify decision-makers & triggers

MessagingRun all 3 segment spines in parallel

TOFU/MOFULaunch ads/content · benchmark + snapshot

SalesTargeted Sales Nav outreach · baseline funnel

Output: which ICP + buyer + problem + message combinations earn more investment.

Days 31–60

VALIDATE

ICPCompare the three segments head-to-head

BuyerOwner vs administrator vs operations

MessageKill weak spines

ChannelGoogle vs LinkedIn vs media vs ABM

MOFU/BOFUOptimize benchmark · grow walkthroughs

ResearchRun the roundtable (T3) · tighten MQL→SQL

Output: validated ICP × buyer × message × channel combinations.

Days 61–90

SCALE

BudgetShift spend to proven combinations

ICPExpand winning segments

MessagingBuild around the strongest spine

ABMDeepen account penetration (esp. T3)

ContentRe-engage high-intent · scale winning formats

SalesFocus high-fit/high-intent · track pipeline

Loop: Test → Learn → Reallocate → Scale.

7.2

Lead scoring & qualification

Engagement / Intent (interest, not confirmed pain)

Behaviour	Signal
Ad click / article read	Low
Video watched	Low–Medium
Benchmark completed / results viewed	Medium
Multiple visits	Medium
Product workflow viewed	High
Snapshot requested	High
Walkthrough requested	Very High

Engagement alone ≠ sales-qualified.

Sales qualification weighting

Area	Weight	Layer
Account fit	40	Know (pre-engagement)
Relevant problem identified	25	Confirm (discovery)
Buyer relevance	15	Know / Confirm
Buying intent	20	Engagement

80–100 sales-ready · 60–79 review/nurture · <60 nurture. A benchmark completion is Engagement, not Qualification.

7.3

How we discover the REAL funnel

Activity	Target	What we learn
ICP interviews	10–15 practices	Actual inquiry / decision journey
Sales conversations	Existing/potential accounts	Objections + buying process
Sales Navigator	100–200 accounts	Which problem-opener gets a reply
Message tests	3 segment spines	Which problem resonates
Benchmark	Broader ICP	Self-reported operating patterns
Account research	500+ accounts	Observable fit signals
Community listening	r/Ophthalmology · ASCRS/ASOA forums	Unfiltered pain in the buyer's own words

Compare what was assumed vs. what the market revealed — that becomes the basis for the second half of the campaign.

7.4

Sales enablement ecosystem

build the hypothesis, let the funnel validate it

Two tiers: a Day-1 hypothesis kit (drafts good enough to start conversations, built from the segmentation) and a Day-90 validated set (rewritten from what discovery and Sales feedback revealed).

Asset	Per-ICP angle	Stage	Tier
Battlecards	T1 speed / lost paid demand · T2 education consistency · T3 standardisation & governance	Sales / BOFU	Day-1 draft → validated
ICP pitch decks	Reordered around each ICP's lead problem	BOFU / Sales	Day-1 draft → validated
One-pagers / leave-behinds	The single angle that lands for that buyer	MOFU / BOFU	Day-90 (earned)
Demo script + environment	The exact patient question that buyer fears (8:47 PM / 11 PM / 40-brand)	BOFU	Day-1 draft
Objection handling	T1 brand-risk · T2 "not an upsell" · T3 governance/security FAQ	Sales	Day-90 (from discovery)
Talk tracks + email/InMail	Owner vs Administrator vs COO phrasing	MOFU / Sales	Day-1 draft → validated
ROI narrative / calculator	T1 funnel economics · T2 attach-rate · T3 call-centre cost	MOFU	Day-90 (claim discipline)
Case studies / testimonials	ZEISS's own: ClearSight/Pannu = T1 · Goel = T2	MOFU / BOFU	Day-90 (earned)
Explainer / workflow videos	T1 intake→consult · T2 lens question answered · T3 multi-brand consistency	TOFU → BOFU	Day-1 draft → validated

Note: the ROI calculator and case studies can't ship on Day 1 — don't claim "increases conversion" before there's evidence. Build the structure early; add numbers once results support them.

Lifecycle: Draft (hypothesis) → Ship → Test in funnel → Learn (Sales feedback) → Refresh → Version. This is the feedback loop (Tab 8) expressed as assets.

Step 8 of 9How much · how we measure

Budget, KPIs & optimization.

This tab

Where the ₹10L goes, the KPIs, what success means, and the optimization loop.

8.1

Budget allocation

₹10.00L · 90 days

Professional ophthalmology media / placementsSegment-routed (Tab 6)

₹2.00L

ABM + Sales Navigator + targeted outreachSeats + external data (labour off-budget)

₹1.75L

Reallocation reserve (released Day 60)The evidence-follows-money line — funds PR from within the ₹10L

₹1.50L

PR / earned mediaPractice networks, magazines & channels — placements + backlinks (Tab 6)

₹1.00L

Benchmark + Snapshot — the learning engineTooling + question design + analysis

₹1.00L

Executive roundtable (T3)Research-first, not pipeline

₹1.00L

Google Search testingActive-intent capture

₹1.00L

RetargetingRe-engage engaged accounts

₹0.50L

Meta testingOnly if fundable to a readable signal; else fold into Google

₹0.25L

The precision channels added in Tab 6 — NPI-verified networks (Sermo/Doximity) and NPI-matched programmatic — aren't a new line; they're funded as a slice of the media/placements and Google/Meta test budgets during DISCOVER, then earn more from the Day-60 reserve only if they beat cost-per-qualified-conversation.

By phase

~⅓ to DISCOVER (all three spines evenly), reserve held, then ~⅓ + the reserve released to proven combinations at Day 60.

By segment (indicative)

~45% T1 · ~35% T2 · ~20% T3.

8.2

KPIs — learning + quality first

Primary — Quality

MQL→SQL acceptance rate; SQL→opportunity rate. Does Sales accept what Marketing sends?

Primary — Learning

Segment-conversion ranking; validated pain hierarchy; winning message per segment; objection + trigger map. The actual product of 90 days.

Efficiency

Cost per qualified conversation (not per lead), per segment. Where to reallocate.

Diagnostic

TOFU: qualified ICP reach, engagement · MOFU: benchmark starts/completions, snapshot requests · BOFU: walkthrough requests, high-intent actions.

Kill-thresholds: a floor for benchmark completion and a ceiling for cost-per-qualified-conversation per spine; breach → reweight or pause at the Day-30 and Day-60 gates.

8.3

What success looks like after 90 days

falsifiable understanding

By Day 90 each of these can be stated with evidence, or the campaign did not succeed.

Highest-performing ICP (ranked, w/ cost per qualified conversation)
Highest-performing buyer (owner vs admin vs COO)
Strongest problem territory per segment
Strongest message per segment (weak ones killed)
Best acquisition channel per segment

Best conversion asset (which enablement asset worked)
Confirmed objection map
Buying triggers
Qualification signals Sales agrees with
Pipeline potential — the commercial case for phase 2

8.4

Optimization & the feedback loop

Unit of optimization

ICP × Buyer × Problem × Message × Channel — optimize the combination, never the channel alone.

Combination	Result
T1 Refractive × Marketing Dir. × after-hours leak × RETURN/ACCESS × Google	Strong
T1 × Physician × "AI" × generic-AI message × LinkedIn	Weak — kill
T2 Cataract × Administrator × off-site decision × INFLUENCE × EyeNet	Testing
T3 PE × COO × variance/governance × CONTROL/CONSISTENCY × Roundtable	Early signal

The feedback loop

Marketing generates engagement → Sales validates the problem → the customer reveals real workflow and objections → Marketing updates the ICP, messaging and assets → test again.

Step 9 of 9Who runs it

Product-marketing-led. The team is the execution engine, not support.

This tab

Who owns what, and how the roles pair up. Production is in-house and off-budget.

The shape

Understand the product → build the positioning → execute + A/B test → learn → MBR → expand.

RACI

Who owns what

Product Marketing lead

Product understanding (RAG, LLMs, data flow, integrations) → segment positioning → strategy, execution, A/B testing → MBR feedback → expansion. Owns measurement + reallocation.

Works with Marketing lead, product, tech

Account Executive (BDR)

CRM, lead handoffs, follow-up, connecting with leads — knows the product. Also owns consultancy referral partners (2.3 / 6.8): outreach, the referral relationship and routing partner-sourced practices, with PM setting the partner strategy.

Works with Social media, Sales, Product Marketing (partner strategy)

Content writer

All copy — built as one storyline per segment.

Works with Video (story) + SEO (optimisation)

SEO specialist

Search/intent, content optimisation, benchmark findability, tracking — plus channel strategy.

Works with Product Marketing + social (channels), writer, team (analytics)

Social media specialist

LinkedIn POV + outbound + Sales Nav, paid social — plus CRM assist and KPI/funnel tracking in GA.

Works with AEs (outbound/CRM), SEO + team (analytics)

Video editor

Scenario videos + BOFU demo.

Works with Writer (shared storylines)

Graphic designer

Visual system + benchmark/snapshot UI + per-ICP decks; ZEISS brand.

Works with Whole team

Ways of working

How the work connects

Positioning, channel strategy and strategizing sit with Product Marketing; execution sits with the team. PM sets the segment positioning from the product's tech capabilities; the team runs it — tests, graphics, videos, copy.

The writer works in two pairs: with video → one storyline becomes blog, email and video; with SEO → copy is optimised at the draft stage, not after. One story, consistent across search, inbox and screen.

Channel strategy is shared — SEO, Product Marketing and social decide where each segment gets reached, since the buyer rotates (owner → administrator → COO).

Outbound is social + AE together — LinkedIn Sales Nav air-cover feeds leads the AE qualifies, routes and follows up in CRM. Analytics is a team effort in GA; PM reads the output and reprioritises.

Ref

Reference links

Ophthalmologist count — AAO: aao.org/eyenet
LASIK volume/cost — NVISION · VisionCenter
LASIK decline / lens shift — EyeWorld
Cataract volume — The World Data
Premium IOL adoption — Navigate Patient Solutions
Private practice / independence — CRSToday · Ophthalmology Management
PE platforms — CT Acquisitions tracker · FOCUS

↑ Back to top

A 90-day campaign that discovers the customer, then scales what wins.

How the campaign reads

The first 90 days buy understanding, not scale.

Read these first

Campaign objective

The four moving parts

1 · Foundation — who & why (Tabs 2–3)

2 · Message & creative (Tab 4)

3 · Execution engine (Tabs 5–6)

4 · Plan & proof (Tabs 7–9)

The idea underneath everything

Market segmentation & pain mapping.

Market context

~18,500

~4,000

~70%

Two engines

The three ICPs

Refractive / Lifestyle Hubs

Premium-Cataract Groups

PE-Backed Platforms

Ophthalmic Practice-Management Consultancies

How we find them (sourcing)

Consolidated pain map

How do we score an ICP if we don't know their pain?

Can observe (pre-engagement)

Cannot yet know

Split by revenue engine.

Refractive Hubs — "they buy their patients"

Premium-Cataract Groups — "patients arrive; a decision must be won"

PE Platforms — "growth by acquisition → owns heterogeneity"

One spine, three expressions.

Shared core positioning

What flexes per segment

Messaging territories to test

Copy directions — two angles per segment

The click is not where the patient is won. It is where they start waiting.

Conversion should not depend on whether your coordinator had a good day.

The lens decision is rarely made in your chair. It is made at home, over weeks.

Your best people should not spend the day answering the same lens questions.

The question is not whether AI belongs in patient communication. It is who is accountable for it.

You standardized billing and scheduling. Patient communication is still forty different answers.

The funnel as a research mechanism.

The customer journey (shared chassis)

Buyer journey by ICP

Owner / Marketing Director

Administrator / Lead Surgeon

Platform COO / VP Ops · ABM

TOFU → MOFU → BOFU mechanics

TOFU — create the question

MOFU — make pain surface

BOFU — experience VisioGen

The full Ad → Sales journey

Channels route by buyer — because the buyer rotates.

Channel strategy

Media placements by segment

Content architecture — one idea per segment

"Respond to the demand you already paid for."

"Be there for the decision you're not in the room for."

"One verified standard. Every location."

Email journey — the 5-beat arc

Sales Navigator strategy — trigger-led

T1 opener

T2 opener

T3 opener

Channel depth & off-page SEO

Depth is deliberate

Off-page SEO + AEO (off-budget)

Executive roundtable (primarily Tier-3 ABM)

Format — "Chairs & Cheers" closed-door roundtable

Referral & channel partners — consultancies

Who

The offer

Why it compounds

Discover → Validate → Scale.

The three phases

Lead scoring & qualification

Engagement / Intent (interest, not confirmed pain)

Sales qualification weighting

How we discover the REAL funnel